Myrexis, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYRX research report →
Price Chart
About the company
Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc.
- CEO
- Jonathan Couchman
- IPO
- 2009
- Employees
- 1
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on MYRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $27.58K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.02
- EV/EBITDA
- 0.09
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -25.67%
- ROIC
- -1031.04%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-11,991,000
- Net Income
- $-11,621,000+62.8%
- EPS
- $-0.39+66.9%
- OCF Growth
- +53.3%
- FCF Growth
- +53.4%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 3.18
- RSI (14)
- 29
- Avg Volume
- 4.77K
No earnings-call transcripts are available for MYRX yet.
- Free Float
- 74.4%
- Shares Outstanding
- 34.48M
- Float Shares
- 25.64M
of shares held by institutions
1 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Guggenheim Funds Investment Advisors, LLC | 56.86K | ▲ 56.86K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 27, 13 | Xstelos Holdings, Inc. | other | 0 |
| Feb 13, 13 | SCHEIWE STEVEN D | other | 0 |
| Feb 13, 13 | Pearce Michael Cooper | other | 0 |
| Jan 22, 13 | COUCHMAN JONATHAN | other | 0 |
| Jan 18, 13 | HENDERSON JOHN T | other | 2,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MYRX coverage
Recent articles, reports, and earnings notes.
No research on MYRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MYRX report →